Parecoxib Sodium CaCCinh-A01 Camphor
glycolate (hydroxyacetate) Doxorubicin (Adriamycin) HCl
4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
PRL-3 Inhibitor I is a potent PRL-3 inhibitor with an IC50 of 0.9 μM. PRL-3 Inhibitor I shows a reduced invasion in cell-based assay.
Solid
IC50: 0.9 μM (PRL-3)
PRL-3 Inhibitor I (compound 5e) reduces the invasion of mouse melanoma B16F10 cells in a cell-based assay.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
Room temperature or refrigerated transportation.
[1]. Ahn JH, et al. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorg Med Chem Lett. 2006;16(11):2996-2999. [Information]
DMSO : 41.67 mg/mL (85.88 mM; ultrasonic and warming and heat to 60°C)
H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)
产品不同,其溶解度不同。建议根据产品选择合适的溶剂配制储备溶液;配成溶液后,建议分装保存,避免反复冻融造成的产品失效。储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时,建议在 6 个月内使用,-20°C 储存时,建议在 1 个月内使用。
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。